The Emerging Role of Neuropeptides in Parkinson’s Disease

Parkinson’s disease (PD), the second most common age-related neurodegenerative disease, results from the loss of dopamine neurons in the substantia nigra. This disease is characterized by cardinal non-motor and motor symptoms. Several studies have demonstrated that neuropeptides, such as ghrelin, ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yanan, Zhang, Linlin, Xie, Junxia, Shi, Limin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982480/
https://www.ncbi.nlm.nih.gov/pubmed/33762925
http://dx.doi.org/10.3389/fnagi.2021.646726
_version_ 1783667726522253312
author Zheng, Yanan
Zhang, Linlin
Xie, Junxia
Shi, Limin
author_facet Zheng, Yanan
Zhang, Linlin
Xie, Junxia
Shi, Limin
author_sort Zheng, Yanan
collection PubMed
description Parkinson’s disease (PD), the second most common age-related neurodegenerative disease, results from the loss of dopamine neurons in the substantia nigra. This disease is characterized by cardinal non-motor and motor symptoms. Several studies have demonstrated that neuropeptides, such as ghrelin, neuropeptide Y, pituitary adenylate cyclase-activating polypeptide, substance P, and neurotensin, are related to the onset of PD. This review mainly describes the changes in these neuropeptides and their receptors in the substantia nigra-striatum system as well as the other PD-related brain regions. Based on several in vitro and in vivo studies, most neuropeptides play a significant neuroprotective role in PD by preventing caspase-3 activation, decreasing mitochondrial-related oxidative stress, increasing mitochondrial biogenesis, inhibiting microglial activation, and anti-autophagic activity. Thus, neuropeptides may provide a new strategy for PD therapy.
format Online
Article
Text
id pubmed-7982480
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79824802021-03-23 The Emerging Role of Neuropeptides in Parkinson’s Disease Zheng, Yanan Zhang, Linlin Xie, Junxia Shi, Limin Front Aging Neurosci Neuroscience Parkinson’s disease (PD), the second most common age-related neurodegenerative disease, results from the loss of dopamine neurons in the substantia nigra. This disease is characterized by cardinal non-motor and motor symptoms. Several studies have demonstrated that neuropeptides, such as ghrelin, neuropeptide Y, pituitary adenylate cyclase-activating polypeptide, substance P, and neurotensin, are related to the onset of PD. This review mainly describes the changes in these neuropeptides and their receptors in the substantia nigra-striatum system as well as the other PD-related brain regions. Based on several in vitro and in vivo studies, most neuropeptides play a significant neuroprotective role in PD by preventing caspase-3 activation, decreasing mitochondrial-related oxidative stress, increasing mitochondrial biogenesis, inhibiting microglial activation, and anti-autophagic activity. Thus, neuropeptides may provide a new strategy for PD therapy. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982480/ /pubmed/33762925 http://dx.doi.org/10.3389/fnagi.2021.646726 Text en Copyright © 2021 Zheng, Zhang, Xie and Shi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zheng, Yanan
Zhang, Linlin
Xie, Junxia
Shi, Limin
The Emerging Role of Neuropeptides in Parkinson’s Disease
title The Emerging Role of Neuropeptides in Parkinson’s Disease
title_full The Emerging Role of Neuropeptides in Parkinson’s Disease
title_fullStr The Emerging Role of Neuropeptides in Parkinson’s Disease
title_full_unstemmed The Emerging Role of Neuropeptides in Parkinson’s Disease
title_short The Emerging Role of Neuropeptides in Parkinson’s Disease
title_sort emerging role of neuropeptides in parkinson’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982480/
https://www.ncbi.nlm.nih.gov/pubmed/33762925
http://dx.doi.org/10.3389/fnagi.2021.646726
work_keys_str_mv AT zhengyanan theemergingroleofneuropeptidesinparkinsonsdisease
AT zhanglinlin theemergingroleofneuropeptidesinparkinsonsdisease
AT xiejunxia theemergingroleofneuropeptidesinparkinsonsdisease
AT shilimin theemergingroleofneuropeptidesinparkinsonsdisease
AT zhengyanan emergingroleofneuropeptidesinparkinsonsdisease
AT zhanglinlin emergingroleofneuropeptidesinparkinsonsdisease
AT xiejunxia emergingroleofneuropeptidesinparkinsonsdisease
AT shilimin emergingroleofneuropeptidesinparkinsonsdisease